-
Notifications
You must be signed in to change notification settings - Fork 54
New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
[Merge] MONDO:0016022 'early myoclonic encephalopathy' #8557
Comments
Note - do not add to list until we've discussed this at the epilepsy workshop on Jan 17, 2025 |
We discussed this at the workshop and it was suggested that I follow up with Elaine Wirrell, I emailed her on 2025-02-05. If we don't hear back, I think it's okay to proceed with this as proposed based on ILAE. |
Additional tasks:
(if I hear back from Eileen, ask her if these should be children of 'early infantile DEE' but based on OMIM descriptions, they do not seem like DEEs) |
Done on PR: #8659 |
…lopathy - update comment - add GitHub link address #8557
Merge Mondo term (ID and Label)
MONDO:0016022 'early myoclonic encephalopathy'
Into:
MONDO:0800491 'early-infantile DEE'.
Suggested revision and reasons
According to ILAE:
"Early-infantile developmental and epileptic encephalopathy syndrome (EIDEE) is characterized by frequent drug-resistant seizures that begin ≤3 months of age, with abnormal interictal EEG and neurological examination. This syndrome encompasses the previous syndromes of Ohtahara syndrome and early myoclonic encephalopathy. Treatable metabolic etiologies (especially pyridoxine and pyridoxal-5-phosphate disorders) should be excluded early."
The text was updated successfully, but these errors were encountered: